Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/27/2007 | WO2007147816A1 Insulinotropic peptide synthesis |
12/27/2007 | WO2007147590A2 Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
12/27/2007 | WO2007147265A1 Polynucleotides and polypeptide sequences involved in cancer |
12/27/2007 | WO2007133476A3 Competitive substrate inhibition to increase drug bioavailability |
12/27/2007 | WO2007130672A3 Urodilatin cancer treatment |
12/27/2007 | WO2007126941A3 Solid support reagents for synthesis |
12/27/2007 | WO2007125226A3 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis |
12/27/2007 | WO2007122424A3 Larval polypeptides having a nuclease activity |
12/27/2007 | WO2007118017A3 Method for preventing increases in postoperative intraocular pressure |
12/27/2007 | WO2007112357A3 Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
12/27/2007 | WO2007109118A9 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS |
12/27/2007 | WO2007106494A3 Methods and compositions for treatment of diastolic heart failure |
12/27/2007 | WO2007101161A8 Methods and compositions for the treatment of gastrointestinal disorders |
12/27/2007 | WO2007091078A3 Polypeptide conjugate comprising hla-g and uses thereof, stem cells transfected with hla-g |
12/27/2007 | WO2007081680A3 Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
12/27/2007 | WO2007069249A9 Toxin-like polypeptides, polynucleotides encoding same and uses thereof |
12/27/2007 | WO2007024700A8 Exendin for treating diabetes and reducing body weight |
12/27/2007 | WO2006135382A3 Enzymatic activities in chemokine-mediated inflammation |
12/27/2007 | WO2006091231A3 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
12/27/2007 | WO2006084139A8 An implantable interferon-containing device |
12/27/2007 | WO2006052668A3 Induction of antigen specific immunologic tolerance |
12/27/2007 | WO2006033024A3 Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds |
12/27/2007 | WO2005094314A3 Modulators of shp2 tyrosine phosphatase and their use in the treatment of body weight disorders |
12/27/2007 | WO2005069859A3 Compositions and methods for modulating dhr96 |
12/27/2007 | WO2005044200A3 Methods and compositions for treating mcp-1 related pathologies |
12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
12/27/2007 | US20070299536 Collagen Mimics |
12/27/2007 | US20070299390 Needleless syringe using supersonic gas flow for particle delivery |
12/27/2007 | US20070299385 Device for the controlled exposure of reservoir-based sensors |
12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
12/27/2007 | US20070299059 Compostions and methods relating to novel compounds and targets thereof |
12/27/2007 | US20070299031 Therapeutic agent for tumor of neural origin |
12/27/2007 | US20070299026 Immunosuppressive Cytokine |
12/27/2007 | US20070299023 P185Neu-Encoding Dna and Therapeutical Uses Thereof |
12/27/2007 | US20070299022 Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia |
12/27/2007 | US20070299016 Specific Antibodies for Diagnosing Heart Failure |
12/27/2007 | US20070299015 Peptide fragments for inducing synthesis of extracellular matrix proteins |
12/27/2007 | US20070299014 Casein hydrolyzate, process for producing the same and use thereof |
12/27/2007 | US20070299013 Exosite-Directed Thrombin Inhibitors |
12/27/2007 | US20070299012 Method of preventing progression of hypertension-induced heart failure with PKC peptides |
12/27/2007 | US20070299011 Appoptosin and uses thereof for treating neurodegenerative disease and cancer |
12/27/2007 | US20070299010 CPG15 and CPG15-2 compounds and inhibitors as insulin receptor and insulin-like growth factor receptor agonists and antagonists |
12/27/2007 | US20070299009 Analogs of parathyroid hormone |
12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
12/27/2007 | US20070299007 Muteins OF Fibroblast Growth Factor 21 |
12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
12/27/2007 | US20070299005 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
12/27/2007 | US20070299004 Methods of providing therapeutic effects using cyclosporin compontnts |
12/27/2007 | US20070299003 Composition Comprising a Pulmonary Surfactant and a Tnf-Derived Peptide |
12/27/2007 | US20070299002 Glucosidase inhibitors; for lowering blood glucose levels and treatment of chronic inflammation |
12/27/2007 | US20070299001 PURIFIED hCG |
12/27/2007 | US20070299000 Method of lowering body fat percentage or inhibiting body fat percentage increase |
12/27/2007 | US20070298999 Method for treating pain with a calmodulin inhibitor |
12/27/2007 | US20070298998 Biomarkers for amyotrophic lateral sclerosis and methods using the same |
12/27/2007 | US20070298997 Compounds useful in treating diabetic microvascular complications and age-related macular degeneration |
12/27/2007 | US20070298996 penile erectile dysfunction; administering a coiled-coil domain of cartilage oligomeric matrix protein linked to a Tie2 receptor binding domain which is a fibrinogen-like domain of angiopoietin-1 |
12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
12/27/2007 | US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
12/27/2007 | US20070298460 Novel receptor that causes cell death |
12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
12/27/2007 | US20070298424 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
12/27/2007 | US20070298117 Compositions and kits comprising a melatonin component and a chondroprotective component |
12/27/2007 | US20070298116 Amorphous, spray-dried powders having a reduced moisture content and a high long term stability |
12/27/2007 | US20070298104 Cyanoisoquinoline compounds and methods of use thereof |
12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
12/27/2007 | US20070298071 Bioactive scaffold for therapeutic and adhesion prevention applications |
12/27/2007 | US20070298066 Biodegradable linkers for molecular therapies |
12/27/2007 | US20070298051 Adjuvants Of Immune Response |
12/27/2007 | US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos) |
12/27/2007 | US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same |
12/27/2007 | US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals |
12/27/2007 | US20070298036 PRO71238 Polypeptides |
12/27/2007 | US20070298032 Proteins Involved In Quorum Sensing |
12/27/2007 | US20070298031 Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin |
12/27/2007 | US20070298029 Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors |
12/27/2007 | US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3) |
12/27/2007 | US20070298027 Novel Target for Antiderpressant Therapy |
12/27/2007 | US20070298025 Pharmaceutical Compositions and Methods for Reducing Body Fat |
12/27/2007 | US20070298024 C-1 inactivator inhibits two-chain urokinase mutant and limits hemostatic bleeding during thrombolysis |
12/27/2007 | US20070298023 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
12/27/2007 | US20070298022 Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action |
12/27/2007 | US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury |
12/27/2007 | US20070298010 For reducing aggregation or immunogenicity of peptide or polypeptide including an alkylglycoside, especially dodecyl maltoside, tridecyl maltoside, sucrose monododecanoate, sucrose monotridecanoate, or sucrose monotetradecanoate; treatment of obesity |
12/27/2007 | US20070298009 protect neural cells from degeneration and/or death in response to traumatic brain injury or autoimmune disorders of the brain, such as multiple sclerosis and in reducing seizures; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease |
12/27/2007 | US20070297999 Kit containing an acidic composition and a composition based on a hydroxyalkyl urea |
12/27/2007 | US20070297991 Neural conduit agent dissemination for smoking cessation and other applications |
12/27/2007 | US20070297986 Screening methods for identifying agents useful for treating or reducing visual impairment in mammals |
12/27/2007 | US20070297984 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses |
12/27/2007 | US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use |
12/27/2007 | US20070297981 Formulations and methods for treating dry eye |
12/27/2007 | US20070297979 Pharmaceutical Compounds |
12/27/2007 | DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent |
12/27/2007 | DE202007012343U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Rezeptur zur Regulierung der Haut Amino acid-mineral-peptide complex, in particular quantum-mechanically modified, as formulation for regulating skin |
12/27/2007 | DE102005063438A1 Verfahren zur Herstellung von porösen Schwämmen aus gereinigtem marinem Kollagen A process for producing porous sponges of purified marine collagen |
12/27/2007 | DE10196235B4 Using collagen from aquatic animals as carriers for tissue engineering, useful e.g. as skin replacements and in screening for antiaging drugs |
12/27/2007 | CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer |
12/27/2007 | CA2714867A1 Non-aggregated pharmaceutically active peptide |
12/27/2007 | CA2659691A1 Modified beta-lactamase and method for its preparation |
12/27/2007 | CA2657213A1 Peptide epoxyketones for proteasome inhibition |